HeartWare is counting on its established HVAD technology to carry it through a difficult period as it struggles to relaunch the clinical trial of the MVAD miniaturized ventricular assist device.
HeartWare paused the MVADvantage clinical trial in September to address problems with the manufacturing and software for the MVAD’s controller,...